Methylphenidate transdermal system (US brand name Daytrana®) is a central nervous system stimulant. Here is basic information about this medication.
Treatment of attention deficit hyperactivity disorder (ADHD) in children (6-12 years) and adolescents (13-17 years)
Initial: 10 mg
Dosage should be titrated to effect. Dose titration, final dosage, and wear time should be individualized according to the needs and response of the patient.
Should be applied to the hip area (using alternating sites) 2 hours before an effect is needed and removed 9 hours after application. May be removed earlier if a shorter duration of effect is desired or late day side effects appear.
Dosage forms and strengths
Extended-release transdermal patch (Daytrana®): 10 mg/9 hr, 15 mg/9 hr, 20 mg/9 hr, and 30 mg/9 hr
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Copyright 2017, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.